Processa Pharmaceuticals, Inc. (PCSA)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 13, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Processa Pharmaceuticals, Inc.'s Preliminary Proxy Statement on Schedule 14A, filed on July 31, 2025. They remind the company and its managemen… | Read Filing EDGAR |
| Aug. 8, 2025 | CORRESP | Neutral/Informational | Low | Processa Pharmaceuticals, Inc. submitted a correspondence to the SEC in response to comments regarding their preliminary proxy statement filed on July 31, 2025. The SEC requested … | Read Filing EDGAR |
| Aug. 6, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Processa Pharmaceuticals, Inc.'s Preliminary Proxy Statement on Schedule 14A filed on July 31, 2025, and has issued a comment requesting additional informatio… | Read Filing EDGAR |
| Jun. 13, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from H.C. Wainwright & Co., LLC, acting as the placement agent for Processa Pharmaceuticals, Inc., requests the acceleration of the effective date for the compa… | Read Filing EDGAR |
| Jun. 13, 2025 | CORRESP | Neutral/Informational | Moderate | Processa Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement on Form S-1. The company seeks to have th… | Read Filing EDGAR |